AI-Powered MRI could revolutionize breast cancer screening without contrast dyes
NCT ID NCT07205276
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether artificial intelligence can analyze non-contrast breast MRI scans to detect cancer early, avoiding the need for contrast agents that can be costly and risky. Researchers plan to enroll 30,000 women aged 30-70 and compare AI readings to standard radiologist interpretations. If successful, this approach could offer a safer, more accessible screening option, especially for women with dense breast tissue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Non-contrast multiparametric breast MRI with AI-based radiomics analysis
What this could lead to
If successful, this could provide a safer, more accurate breast cancer screening method that avoids contrast agents and works well for women with dense breast tissue.
What could go wrong
The AI model is still being developed and validated; it may not perform as well in real-world settings or across diverse populations. The trial is not yet recruiting, so results are years away.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••